The role of vertebrate models in understanding craniosynostosis

Child's Nervous System

Volumn 28, Issue 9, 2012, Pages 1471-1481

  Holmes, Greg ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Calvaria; Craniosynostosis; Mouse; Rabbit; Rat; Suture

Indexed keywords

EPHRIN B1; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; JAGGED1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NOGGIN; SONIC HEDGEHOG PROTEIN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR GLI3; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ACROCEPHALOSYNDACTYLY; ALAGILLE SYNDROME; ARTICLE; CALVARIA; CHEMICAL ANALYSIS; CHICKEN; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; CROUZON SYNDROME; DISEASE MODEL; GENE; GENE EXPRESSION; GENE THERAPY; GENETIC MODEL; GENETICS; HUMAN; LOSS OF FUNCTION MUTATION; MEDICAL RESEARCH; MORPHOLOGY; MUENKE SYNDROME; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; SKULL SURGERY; TWIST1 GENE; VERTEBRATE; XENOPUS LAEVIS; ZEBRA FISH;

ANIMALS; ANURA; CHICKENS; CRANIOSYNOSTOSES; DISEASE MODELS, ANIMAL; HUMANS; MICE; RABBITS; RATS; SKULL; VERTEBRATES; ZEBRAFISH;

EID: 84866061923     PISSN: 02567040     EISSN: 14330350     Source Type: Journal    
DOI: 10.1007/s00381-012-1844-3     Document Type: Article

References (127)

1. Morriss-Kay GM, Wilkie AO (2005) Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. J Anat 207:637-653
2. Mooney MP, Siegel MI, Opperman LA (2002) Animal models of craniosynostosis: experimental, congenital, and transgenic models. In: Mooney MP, Siegel MI (eds) Understanding craniofacial anomalies: the etiopathogenesis of craniosynostoses and facial clefting. Wiley-Liss, Inc., New York, pp 209-249
3. Boulet SL, Rasmussen SA, Honein MA (2008) A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A 146A:984-991
4. Cohen MM Jr (2000) Epidemiology of craniosynostosis. In: Cohen MM Jr, MacLean RE (eds) Craniosynostosis: diagnosis, evaluation, and management, 2nd edn. Oxford University Press, New York, pp 112-118
5. Lajeunie E, Le Merrer M, Bonaiti-Pellie C, Marchac D, Renier D (1995) Genetic study of nonsyndromic coronal craniosynostosis. Am J Med Genet 55:500-504
6. Wilkie AO, Byren JC, Hurst JA, Jayamohan J, Johnson D, Knight SJ, Lester T, Richards PG, Twigg SR, Wall SA (2010) Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis. Pediatrics 126:391-400
7. Johnson D, Wilkie AO (2011) Craniosynostosis. Eur J Hum Genet 19:369-376
8. Gomes PS, Fernandes MH (2011) Rodent models in bone-related research: the relevance of calvarial defects in the assessment of bone regeneration strategies. Lab Anim 45:14-24
9. Gondo Y (2010) Now and future of mouse mutagenesis for human disease models. J Genet Genomics 37:559-572
10. Justice MJ, Siracusa LD, Stewart AF (2011) Technical approaches for mouse models of human disease. Dis Model Mech 4:305-310
11. Szpalski C, Barr J, Wetterau M, Saadeh PB, Warren SM (2010) Cranial bone defects: current and future strategies. Neurosurg Focus 29:E8
12. Warren SM, Greenwald JA, Spector JA, Bouletreau P, Mehrara BJ, Longaker MT (2001) New developments in cranial suture research. Plast Reconstr Surg 107:523-540
13. Lewanda AF, Jabs EW (2007) Craniosynostosis. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR (eds) Emery & Rimoin's principles and practice of medical genetics, 5th edn. Churchill Livingstone, Philadelphia, pp 3359-3379
14. Zhou YX, Xu X, Chen L, Li C, Brodie SG, Deng CX (2000) A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet 9:2001-2008
15. Chen L, Li D, Li C, Engel A, Deng CX (2003) A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 33:169-178
16. Holmes G, Rothschild G, Roy UB, Deng CX, Mansukhani A, Basilico C (2009) Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology. Dev Biol 328:273-284
17. Wang Y, Xiao R, Yang F, Karim BO, Iacovelli AJ, Cai J, Lerner CP, Richtsmeier JT, Leszl JM, Hill CA, Yu K, Ornitz DM, Elisseeff J, Huso DL, Jabs EW (2005) Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Development 132:3537-3548
18. Wang Y, Sun M, Uhlhorn VL, Zhou X, Peter I, Martinez-Abadias N, Hill CA, Percival CJ, Richtsmeier JT, Huso DL, Jabs EW (2010) Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice. BMC Dev Biol 10:22
19. Yin L, Du X, Li C, Xu X, Chen Z, Su N, Zhao L, Qi H, Li F, Xue J (2008) A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis. Bone 42:631-643
20. Hajihosseini MK, Wilson S, De Moerlooze L, Dickson C (2001) A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes. Proc Natl Acad Sci U S A 98:3855-3860
21. Holmes G, Basilico C (2012) Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome. Dev Biol (in press) doi: 10.1016/j.ydbio.2012.05.026
22. Renier D, Lajeunie E, Arnaud E, Marchac D (2000) Management of craniosynostoses. Childs Nerv Syst 16:645-658
23. Kreiborg S, Cohen MM Jr (1998) Is craniofacial morphology in Apert and Crouzon syndromes the same? Acta Odontol Scand 56:339-341
24. Eswarakumar VP, Horowitz MC, Locklin R, Morriss-Kay GM, Lonai P (2004) A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc Natl Acad Sci U S A 101:12555-12560
25. Mai S, Wei K, Flenniken A, Adamson SL, Rossant J, Aubin JE, Gong SG (2010) The missense mutation W290R in Fgfr2 causes developmental defects from aberrant IIIb and IIIc signaling. Dev Dyn 239:1888-1900
26. Wang Y, Zhou X, Oberoi K, Phelps R, Couwenhoven R, Sun M, Rezza A, Holmes G, Percival CJ, Friedenthal J, Krejci P, Richtsmeier JT, Huso DL, Rendl M, Jabs EW (2012) p38 inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice. J Clin Invest 122:2153-2164
27. Twigg SR, Healy C, Babbs C, Sharpe JA, Wood WG, Sharpe PT, Morriss-Kay GM, Wilkie AO (2009) Skeletal analysis of the Fgfr3(P244R) mouse, a genetic model for the Muenke craniosynostosis syndrome. Dev Dyn 238:331-342
28. Purushothaman R, Cox TC, Muga AM, Cunningham ML (2011) Facial suture synostosis of newborn Fgfr1(P250R/+) and Fgfr2(S252W/+) mouse models of Pfeiffer and Apert syndromes. Birth Defects Res A Clin Mol Teratol 91:603-609
29. Aldridge K, Hill CA, Austin JR, Percival C, Martinez-Abadias N, Neuberger T, Wang Y, Jabs EW, Richtsmeier JT (2010) Brain phenotypes in two FGFR2 mouse models for Apert syndrome. Dev Dyn 239:987-997
30. Martinez-Abadias N, Heuze Y, Wang Y, Jabs EW, Aldridge K, Richtsmeier JT (2011) FGF/FGFR signaling coordinates skull development by modulating magnitude of morphological integration: evidence from Apert syndrome mouse models. PLoS One 6:e26425
31. Martinez-Abadias N, Percival C, Aldridge K, Hill CA, Ryan T, Sirivunnabood S, Wang Y, Jabs EW, Richtsmeier JT (2010) Beyond the closed suture in Apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth. Dev Dyn 239:3058-3071
32. Perlyn CA, DeLeon VB, Babbs C, Govier D, Burell L, Darvann T, Kreiborg S, Morriss-Kay G (2006) The craniofacial phenotype of the Crouzon mouse: analysis of a model for syndromic craniosynostosis using three-dimensional MicroCT. Cleft Palate Craniofac J 43:740-748
33. Olafsdottir H, Darvann TA, Hermann NV, Oubel E, Ersboll BK, Frangi AF, Larsen P, Perlyn CA, Morriss-Kay GM, Kreiborg S (2007) Computational mouse atlases and their application to automatic assessment of craniofacial dysmorphology caused by the Crouzon mutation Fgfr2(C342Y). J Anat 211:37-52
34. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM (2002) Tissue origins and interactions in the mammalian skull vault. Dev Biol 241:106-116
35. Yoshida T, Vivatbutsiri P, Morriss-Kay G, Saga Y, Iseki S (2008) Cell lineage in mammalian craniofacial mesenchyme. Mech Dev 125:797-808
36. Carver EA, Oram KF, Gridley T (2002) Craniosynostosis in Twist heterozygous mice: a model for Saethre-Chotzen syndrome. Anat Rec 268:90-92
37. Merrill AE, Bochukova EG, Brugger SM, Ishii M, Pilz DT, Wall SA, Lyons KM, Wilkie AO, Maxson RE (2006) Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis. Hum Mol Genet 15:1319-1328
38. Ting MC, Wu NL, Roybal PG, Sun J, Liu L, Yen Y, Maxson RE Jr (2009) EphA4 as an effector of Twist1 in the guidance of osteogenic precursor cells during calvarial bone growth and in craniosynostosis. Development 136:855-864
39. Yen HY, Ting MC, Maxson RE (2010) Jagged1 functions downstream of Twist1 in the specification of the coronal suture and the formation of a boundary between osteogenic and non-osteogenic cells. Dev Biol 347:258-270
40. Rice DP, Aberg T, Chan Y, Tang Z, Kettunen PJ, Pakarinen L, Maxson RE, Thesleff I (2000) Integration of FGF and TWIST in calvarial bone and suture development. Development 127:1845-1855
41. Connerney J, Andreeva V, Leshem Y, Mercado MA, Dowell K, Yang X, Lindner V, Friesel RE, Spicer DB (2008) Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Dev Biol 318:323-334
42. Connerney J, Andreeva V, Leshem Y, Muentener C, Mercado MA, Spicer DB (2006) Twist1 dimer selection regulates cranial suture patterning and fusion. Dev Dyn 235:1345-1357
43. Eswarakumar VP, Ozcan F, Lew ED, Bae JH, Tomé F, Booth CJ, Adams DJ, Lax I, Schlessinger J (2006) Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis. Proc Natl Acad Sci U S A 103:18603-18608
44. Bush JO, Soriano P (2009) Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism. Genes Dev 23:1586-1599
45. Ito Y, Yeo JY, Chytil A, Han J, Bringas P Jr, Nakajima A, Shuler CF, Moses HL, Chai Y (2003) Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development 130:5269-5280
46. Dudas M, Kim J, Li WY, Nagy A, Larsson J, Karlsson S, Chai Y, Kaartinen V (2006) Epithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusion. Dev Biol 296:298-314
47. Schmidt K, Hughes C, Chudek JA, Goodyear SR, Aspden RM, Talbot R, Gundersen TE, Blomhoff R, Henderson C, Wolf CR, Tickle C (2009) Cholesterol metabolism: the main pathway acting downstream of cytochrome P450 oxidoreductase in skeletal development of the limb. Mol Cell Biol 29:2716-2729
48. Gunther T, Struwe M, Aguzzi A, Schughart K (1994) Open brain, a new mouse mutant with severe neural tube defects, shows altered gene expression patterns in the developing spinal cord. Development 120:3119-3130
49. Kasarskis A, Manova K, Anderson KV (1998) A phenotype-based screen for embryonic lethal mutations in the mouse. Proc Natl Acad Sci U S A 95:7485-7490
50. Laurita J, Koyama E, Chin B, Taylor JA, Lakin GE, Hankenson KD, Bartlett SP, Nah HD (2011) The Muenke syndrome mutation (FgfR3P244R) causes cranial base shortening associated with growth plate dysfunction and premature perichondrial ossification in murine basicranial synchondroses. Dev Dyn 240:2584-2596
51. Behr B, Longaker MT, Quarto N (2010) Differential activation of canonical Wnt signaling determines cranial sutures fate: a novel mechanism for sagittal suture craniosynostosis. Dev Biol 344:922-940
52. Behr B, Longaker MT, Quarto N (2011) Craniosynostosis of coronal suture in Twist1 mice occurs through endochondral ossification recapitulating the physiological closure of posterior frontal suture. Front Physiol 2:37
53. Sanchez-Lara PA, Carmichael SL, Graham JM Jr, Lammer EJ, Shaw GM, Ma C, Rasmussen SA (2010) Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Genet A 152A:394-400
54. Chen JH, Liu C, You L, Simmons CA (2010) Boning up on Wolff's Law: mechanical regulation of the cells that make and maintain bone. J Biomech 43:108-118
55. Oppenheimer AJ, Rhee ST, Goldstein SA, Buchman SR (2012) Force-induced craniosynostosis via paracrine signaling in the murine sagittal suture. J Craniofac Surg 23:573-577
56. Oppenheimer AJ, Rhee ST, Goldstein SA, Buchman SR (2009) Force-induced craniosynostosis in the murine sagittal suture. Plast Reconstr Surg 124:1840-1848
57. Koskinen-Moffett L (1986) An in vivo experimental model for prenatal craniosynostosis. J Dent Res 65:278
58. Jacob S, Wu C, Freeman T, Koyama E, Kirschner R (2007) Expression of Indian hedgehog, BMP-4 and Noggin in craniosynostosis induced by fetal constraint. Ann Plast Surg 58:215-221
59. Kirschner RE, Gannon FH, Xu J, Wang J, Karmacharya J, Bartlett SP, Whitaker LA (2002) Craniosynostosis and altered patterns of fetal TGF-beta expression induced by intrauterine constraint. Plast Reconstr Surg 109:2338-2346
60. Smartt JM Jr, Karmacharya J, Gannon FH, Teixeira C, Mansfield K, Hunenko O, Shapiro IM, Kirschner RE (2005) Intrauterine fetal constraint induces chondrocyte apoptosis and premature ossification of the cranial base. Plast Reconstr Surg 116:1363-1369
61. Mehrara BJ, Spector JA, Greenwald JA, Ueno H, Longaker MT (2002) Adenovirus-mediated transmission of a dominant negative transforming growth factor-beta receptor inhibits in vitro mouse cranial suture fusion. Plast Reconstr Surg 110:506-514
62. Yu P, Gosain AK, Khanna A (2001) The role of transforming growth factor-beta in the modulation of mouse cranial suture fusion. Plast Reconstr Surg 108:916-924
63. Cooper GM, Usas A, Olshanski A, Mooney MP, Losee JE, Huard J (2009) Ex vivo Noggin gene therapy inhibits bone formation in a mouse model of postoperative resynostosis. Plast Reconstr Surg 123:94S-103S
64. Perlyn C, Morriss-Kay G, Darvann T, Tenenbaum M, Ornitz DM (2006) A model for the pharmacological treatment of Crouzon syndrome. Neurosurgery 59:210-215
65. Shukla V, Coumoul X, Wang R, Kim H, Deng CX (2007) RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nat Genet 39:1145-1150
66. Levine JP, Bradley JP, Roth DA, McCarthy JG, Longaker MT (1998) Studies in cranial suture biology: regional dura mater determines overlying suture biology. Plast Reconstr Surg 101:1441-1447
67. Opperman LA, Sweeney TM, Redmon J, Persing JA, Ogle RC (1993) Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev Dyn 198:312-322
68. Roth DA, Bradley JP, Levine JP, McMullen HF, McCarthy JG, Longaker MT (1996) Studies in cranial suture biology: part II. Role of the dura in cranial suture fusion. Plast Reconstr Surg 97:693-699
69. Slater BJ, Kwan MD, Gupta DM, Lee JK, Longaker MT (2009) The role of regional posterior frontal dura mater in the overlying suture morphology. Plast Reconstr Surg 123:463-469
70. Opperman LA, Nolen AA, Ogle RC (1997) TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Miner Res 12:301-310
71. Opperman LA, Adab K, Gakunga PT (2000) Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev Dyn 219:237-247
72. Opperman LA, Chhabra A, Cho RW, Ogle RC (1999) Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro. J Craniofac Genet Dev Biol 19:164-173
73. Greenwald JA, Mehrara BJ, Spector JA, Warren SM, Fagenholz PJ, Smith LE, Bouletreau PJ, Crisera FE, Ueno H, Longaker MT (2001) In vivo modulation of FGF biological activity alters cranial suture fate. Am J Pathol 158:441-452
74. Aghaloo T, Cowan CM, Chou YF, Zhang X, Lee H, Miao S, Hong N, Kuroda S, Wu B, Ting K, Soo C (2006) Nell-1-induced bone regeneration in calvarial defects. Am J Pathol 169:903-915
75. Li W, Zara JN, Siu RK, Lee M, Aghaloo T, Zhang X, Wu BM, Gertzman AA, Ting K, Soo C (2011) Nell-1 enhances bone regeneration in a rat critical-sized femoral segmental defect model. Plast Reconstr Surg 127:580-587
76. Opperman LA, Moursi AM, Sayne JR, Wintergerst AM (2002) Transforming growth factor-beta 3(Tgf-beta3) in a collagen gel delays fusion of the rat posterior interfrontal suture in vivo. Anat Rec 267:120-130
77. Shen K, Krakora SM, Cunningham M, Singh M, Wang X, Hu FZ, Post JC, Ehrlich GD (2009) Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model. Orthod Craniofac Res 12:254-262
78. Warren SM, Brunet LJ, Harland RM, Economides AN, Longaker MT (2003) The BMP antagonist Noggin regulates cranial suture fusion. Nature 422:625-629
79. Heller J, Gabbay J, Wasson K, Mitchell S, Heller M, Zuk P, Bradley J (2007) Cranial suture response to stress: expression patterns of Noggin and Runx2. Plast Reconstr Surg 119:2037-2045
80. Mooney MP, Losken HW, Siegel MI, Lalikos JF, Losken A, Smith TD, Burrows AM (1994) Development of a strain of rabbits with congenital simple nonsyndromic coronal suture synostosis. Part I: breeding demographics, inheritance pattern, and craniofacial anomalies. Cleft Palate Craniofac J 31:1-7
81. Mooney MP, Siegel MI, Burrows AM, Smith TD, Losken HW, Dechant J, Cooper G, Fellows-Mayle W, Kapucu MR, Kapucu LO (1998) A rabbit model of human familial, nonsyndromic unicoronal suture synostosis. II. Intracranial contents, intracranial volume, and intracranial pressure. Childs Nerv Syst 14:247-255
82. Mooney MP, Siegel MI, Burrows AM, Smith TD, Losken HW, Dechant J, Cooper G, Kapucu MR (1998) A rabbit model of human familial, nonsyndromic unicoronal suture synostosis. I. Synostotic onset, pathology, and sutural growth patterns. Childs Nerv Syst 14:236-246
83. Chong SL, Mitchell R, Moursi AM, Winnard P, Losken HW, Bradley J, Ozerdem OR, Azari K, Acarturk O, Opperman LA, Siegel MI, Mooney MP (2003) Rescue of coronal suture fusion using transforming growth factor-beta 3 (Tgf-beta 3) in rabbits with delayed-onset craniosynostosis. Anat Rec A Discov Mol Cell Evol Biol 274:962-971
84. Frazier BC, Mooney MP, Losken HW, Barbano T, Moursi A, Siegel MI, Richtsmeier JT (2008) Comparison of craniofacial phenotype in craniosynostotic rabbits treated with anti-Tgf-beta2 at suturectomy site. Cleft Palate Craniofac J 45:571-582
85. Mooney MP, Losken HW, Moursi AM, Bradley J, Azari K, Acarturk TO, Cooper GM, Thompson B, Opperman LA, Siegel MI (2007) Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits. Plast Reconstr Surg 119:1200-1212
86. Mooney MP, Losken HW, Moursi AM, Shand JM, Cooper GM, Curry C, Ho L, Burrows AM, Stelnicki EJ, Losee JE, Opperman LA, Siegel MI (2007) Postoperative anti-Tgf-beta2 antibody therapy improves intracranial volume and craniofacial growth in craniosynostotic rabbits. J Craniofac Surg 18:336-346
87. Cooper GM, Curry C, Barbano TE, Burrows AM, Vecchione L, Caccamese JF, Norbutt CS, Costello BJ, Losee JE, Moursi AM, Huard J, Mooney MP (2007) Noggin inhibits postoperative resynostosis in craniosynostotic rabbits. J Bone Miner Res 22:1046-1054
88. Cray J Jr, Burrows AM, Vecchione L, Caccamese JF Jr, Losee JE, Moursi AM, Siegel MI, Cooper GM, Mooney MP (2011) Blocking bone morphogenetic protein function using in vivo Noggin therapy does not rescue premature suture fusion in rabbits with delayed-onset craniosynostosis. Plast Reconstr Surg 127:1163-1172
89. Duranthon V, Beaujean N, Brunner M, Odening KE, Santos AN, Kacskovics I, Hiripi L, Weinstein EJ, Bosze Z (2012) On the emerging role of rabbit as human disease model and the instrumental role of novel transgenic tools. Transgenic Res (in press) doi: 10.1007/s11248-012-9599-x
90. Sauka-Spengler T, Barembaum M (2008) Gain- and loss-of-function approaches in the chick embryo. Methods Cell Biol 87:237-256
91. Stern CD (2005) The chick: a great model system becomes even greater. Dev Cell 8:9-17
92. Jheon AH, Schneider RA (2009) The cells that fill the bill: neural crest and the evolution of craniofacial development. J Dent Res 88:12-21
93. Holleville N, Quilhac A, Bontoux M, Monsoro-Burq AH (2003) BMP signals regulate Dlx5 during early avian skull development. Dev Biol 257:177-189
94. Evans DJ, Noden DM (2006) Spatial relations between avian craniofacial neural crest and paraxial mesoderm cells. Dev Dyn 235:1310-1325
95. Lawson ND, Wolfe SA (2011) Forward and reverse genetic approaches for the analysis of vertebrate development in the zebrafish. Dev Cell 21:48-64
96. Quarto N, Longaker MT (2005) The zebrafish (Danio rerio): a model system for cranial suture patterning. Cells Tissues Organs 181:109-118
97. Neuhauss SC, Solnica-Krezel L, Schier AF, Zwartkruis F, Stemple DL, Malicki J, Abdelilah S, Stainier DY, Driever W (1996) Mutations affecting craniofacial development in zebrafish. Development 123:357-367
98. Yelick PC, Schilling TF (2002) Molecular dissection of craniofacial development using zebrafish. Crit Rev Oral Biol Med 13:308-322
99. Andreeva V, Connolly MH, Stewart-Swift C, Fraher D, Burt J, Cardarelli J, Yelick PC (2011) Identification of adult mineralized tissue zebrafish mutants. Genesis 49:360-366
100. Laue K, Pogoda HM, Daniel PB, van Haeringen A, Alanay Y, von Ameln S, Rachwalski M, Morgan T, Gray MJ, Breuning MH, Sawyer GM, Sutherland-Smith AJ, Nikkels PG, Kubisch C, Bloch W, Wollnik B, Hammerschmidt M, Robertson SP (2011) Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid. Am J Hum Genet 89:595-606
101. Rooryck C, Diaz-Font A, Osborn DP, Chabchoub E, Hernandez-Hernandez V, Shamseldin H, Kenny J, Waters A, Jenkins D, Kaissi AA, Leal GF, Dallapiccola B, Carnevale F, Bitner-Glindzicz M, Lees M, Hennekam R, Stanier P, Burns AJ, Peeters H, Alkuraya FS, Beales PL (2011) Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome. Nat Genet 43:197-203
102. Parsons KJ, Andreeva V, James Cooper W, Yelick PC, Craig Albertson R (2011) Morphogenesis of the zebrafish jaw: development beyond the embryo. Methods Cell Biol 101:225-248
103. Slater BJ, Liu KJ, Kwan MD, Quarto N, Longaker MT (2009) Cranial osteogenesis and suture morphology in Xenopus laevis: a unique model system for studying craniofacial development. PLoS One 4:e3914
104. Gross JB, Hanken J (2005) Cranial neural crest contributes to the bony skull vault in adult Xenopus laevis: insights from cell labeling studies. J Exp Zool B Mol Dev Evol 304:169-176
105. Ogino H, Ochi H (2009) Resources and transgenesis techniques for functional genomics in Xenopus. Develop Growth Differ 51:387-401
106. Bialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N, Wu H, Yu K, Ornitz DM, Olson EN, Justice MJ, Karsenty G (2004) A twist code determines the onset of osteoblast differentiation. Dev Cell 6:423-435
107. Liu YH, Kundu R, Wu L, Luo W, Ignelzi MA, Snead ML, Maxson RE (1995) Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc Natl Acad Sci U S A 92:6137-6141
108. Vissers LE, Cox TC, Maga AM, Short KM, Wiradjaja F, Janssen IM, Jehee F, Bertola D, Liu J, Yagnik G, Sekiguchi K, Kiyozumi D, van Bokhoven H, Marcelis C, Cunningham ML, Anderson PJ, Boyadjiev SA, Passos-Bueno MR, Veltman JA, Smyth I, Buckley MF, Roscioli T (2011) Heterozygous mutations of FREM1 are associated with an increased risk of isolated metopic craniosynostosis in humans and mice. PLoS Genet 7:e1002278
109. Hui CC, Joyner AL (1993) A mouse model of Greig cephalopolysyndactyly syndrome: the extra-toesJ mutation contains an intragenic deletion of the Gli3 gene. Nat Genet 3:241-246
110. Rice DP, Connor EC, Veltmaat JM, Lana-Elola E, Veistinen L, Tanimoto Y, Bellusci S, Rice R (2010) Gli3Xt-J/Xt-J mice exhibit lambdoid suture craniosynostosis which results from altered osteoprogenitor proliferation and differentiation. Hum Mol Genet 19:3457-3467
111. Carlton MB, Colledge WH, Evans MJ (1998) Crouzon-like craniofacial dysmorphology in the mouse is caused by an insertional mutation at the Fgf3/Fgf4 locus. Dev Dyn 212:242-249
112. Jehee FS, Bertola DR, Yelavarthi KK, Krepischi-Santos AC, Kim C, Vianna-Morgante AM, Vermeesch JR, Passos-Bueno MR (2007) An 11q11-q13.3 duplication, including FGF3 and FGF4 genes, in a patient with syndromic multiple craniosynostoses. Am J Med Genet A 143A:1912-1918
113. Harada M, Murakami H, Okawa A, Okimoto N, Hiraoka S, Nakahara T, Akasaka R, Shiraishi Y, Futatsugi N, Mizutani-Koseki Y, Kuroiwa A, Shirouzu M, Yokoyama S, Taiji M, Iseki S, Ornitz DM, Koseki H (2009) FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion. Nat Genet 41:289-298
114. Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, Lonai P (2002) The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129:3783-3793
115. De Moerlooze L, Spencer-Dene B, Revest JM, Hajihosseini M, Rosewell I, Dickson C (2000) An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 127:483-492
116. Zhang X, Kuroda S, Carpenter D, Nishimura I, Soo C, Moats R, Iida K, Wisner E, Hu FY, Miao S, Beanes S, Dang C, Vastardis H, Longaker M, Tanizawa K, Kanayama N, Saito N, Ting K (2002) Craniosynostosis in transgenic mice overexpressing Nell-1. J Clin Invest 110:861-870
117. Yu HM, Jerchow B, Sheu TJ, Liu B, Costantini F, Puzas JE, Birchmeier W, Hsu W (2005) The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development 132:1995-2005
118. Li C, Scott DA, Hatch E, Tian X, Mansour SL (2007) Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development. Development 134:167-176
119. Settle SH Jr, Rountree RB, Sinha A, Thacker A, Higgins K, Kingsley DM (2003) Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev Biol 254:116-130
120. Moenning A, Jager R, Egert A, Kress W, Wardelmann E, Schorle H (2009) Sustained platelet-derived growth factor receptor alpha signaling in osteoblasts results in craniosynostosis by overactivating the phospholipase C-gamma pathway. Mol Cell Biol 29:881-891
121. Maeno T, Moriishi T, Yoshida CA, Komori H, Kanatani N, Izumi S, Takaoka K, Komori T (2011) Early onset of Runx2 expression caused craniosynostosis, ectopic bone formation, and limb defects. Bone 49:673-682
122. Compagni A, Logan M, Klein R, Adams RH (2003) Control of skeletal patterning by ephrinB1-EphB interactions. Dev Cell 5:217-230
123. Davy A, Aubin J, Soriano P (2004) Ephrin-B1 forward and reverse signaling are required during mouse development. Genes Dev 18:572-583
124. Mann MB, Hodges CA, Barnes E, Vogel H, Hassold TJ, Luo G (2005) Defective sister-chromatid cohesion, aneuploidy and cancer predisposition in a mouse model of type II Rothmund-Thomson syndrome. Hum Mol Genet 14:813-825
125. Eggenschwiler JT, Espinoza E, Anderson KV (2001) Rab23 is an essential negative regulator of the mouse Sonic hedgehog signalling pathway. Nature 412:194-198
126. Henderson CJ, Otto DM, Carrie D, Magnuson MA, McLaren AW, Rosewell I, Wolf CR (2003) Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J Biol Chem 278:13480-13486
127. Nieminen P, Morgan NV, Fenwick AL, Parmanen S, Veistinen L, Mikkola ML, van der Spek PJ, Giraud A, Judd L, Arte S, Brueton LA, Wall SA, Mathijssen IM, Maher ER, Wilkie AO, Kreiborg S, Thesleff I (2011) Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. Am J Hum Genet 89:67-81